Praveen Tipirneni

CEO, Morphic Therapeutic
Boston, Massachusetts,United States
Find Praveen Tipirneni's Email
Find Praveen Tipirneni's Phone

Who Is Praveen Tipirneni?

Total Experience23 years
CompanyMorphic Therapeutic
CountryUnited States

Praveen Tipirneni is a distinguished leader in the biopharmaceutical industry, currently serving as the President and Chief Executive Officer of Morphic Therapeutic. With a unique and powerful combination of medical and business expertise, he has successfully guided Morphic in its mission to develop a new generation of oral integrin therapies. Dr. Tipirneni began his career as a physician after earning his M.D., later transitioning into the financial sector as an equity research analyst. He then built an impressive track record in corporate development and strategy at major companies like MedImmune/AstraZeneca and Cubist Pharmaceuticals before taking the helm at Morphic in 2016. His leadership is characterized by a deep scientific understanding and a strategic vision for bringing innovative treatments to patients.

How Did Praveen Tipirneni's Career Path Shape Their Journey?

Praveen Tipirneni's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Morphic Therapeutic - CEO(2015 to Present)
Cubist Pharmaceuticals - Senior Vice President, Corporate Development and Global Strategy(2002 to 2015)
Deltagen - Corporate Development(2001 to 2002)

What Are Praveen Tipirneni's Key Achievements?

Leadership and IPO of Morphic Therapeutic

As President and CEO, he successfully led Morphic Therapeutic through a period of significant growth, culminating in a successful Initial Public Offering (IPO) on the NASDAQ (MORF) in 2019. He continues to oversee the clinical advancement of the company's promising pipeline of oral integrin inhibitors.

Pivotal Strategic Transactions at Cubist

During his time as SVP of Corporate Development at Cubist Pharmaceuticals, he was instrumental in executing key M&A and licensing deals, including the strategic acquisitions of Trius Therapeutics and Optimer Pharmaceuticals, which substantially strengthened Cubist's portfolio prior to its own acquisition by Merck.

Bridging Medicine and Business

Successfully leveraged his dual background, holding an M.D. from the University of Miami and an M.B.A. from the Wharton School, to transition from a medical doctor to a key executive in the biopharma industry, excelling in roles across finance, business development, and corporate leadership.

What's Praveen Tipirneni's Educational Background?

MBA, Healthcare Finance

The Wharton School - Year 1998

MD, Medicine

McGill University - Year 1991

BS, Mechanical Engineering

Massachusetts Institute of Technology - Year 1986

Buying Intent Signals for Praveen Tipirneni

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Morphic Therapeutic
Total employees118
HeadquartersWaltham
Founded2014

Morphic Therapeutic is a clinical-stage biopharmaceutical company dedicated to developing a new generation of oral small-molecule medicines that target integrins. Integrins are a family of proteins that play a critical role in cell-to-cell and cell-to-matrix interactions, implicated in a wide range of diseases. By leveraging its proprietary MInT Platform, the company aims to create highly selective, orally-administered integrin inhibitors to treat serious chronic conditions, including autoimmune, cardiovascular, and fibrotic diseases, offering a more convenient alternative to injectable biologic therapies.

Morphic Therapeutic Stock Information
Morphic Therapeutic, Inc. is listed on the NASDAQ under the ticker symbol MORF. The company went public on June 27, 2019

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.